Glenmark Pharma rallied nearly 9% to Rs 1,763.90 after the US drug regulator issued Form 483 with zero observations for its formulation manufacturing facility in Aurangabad.
Subscribe To Our Free Newsletter |
Glenmark Pharma rallied nearly 9% to Rs 1,763.90 after the US drug regulator issued Form 483 with zero observations for its formulation manufacturing facility in Aurangabad.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!